December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan
Aug 16, 2024, 14:58

Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan

Chadi Nabhan, Chief Medical Officer and Head of Strategy of Ryght, shared on X:

Can we fight burnout? Can we improve wellbeing of physicians? ⁦Ishwaria Subbiah of ⁦Sarah Cannon Docs is working tirelessly 2 make it happen. We discussed on Healthcare Unfiltered her initiatives and what can be done. Clip below and full link here.

Ishwaria Subbiah shared the following post adding:

Healthcare professional well being and burnout are ‘actionable’ in ‘meaningful’ and ‘measurable’ ways, but only if organizations shape their approach appropriately! Otherwise, the risk for boiling the ocean is high.

Check out my episode on Healthcare Unfiltered podcast with Chadi Nabhan. Thanks for making time for this important discussion, Chadi.”

Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan

Source: Chadi Nabhan/X and Ishwaria Subbiah/X

Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). She is also the medical director of supportive care oncology, health equity and professional well being at The US Oncology Network. Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US.

Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.